GeneBioTech Co. ,Ltd (KOSDAQ:086060)
South Korea · Delayed Price · Currency is KRW 4,340.00
-35.00 (-0.80%)
At close: May 8, 2026
GeneBioTech Co. ,Ltd Market Cap
GeneBioTech Co. ,Ltd has a market cap or net worth of 35.65 billion as of May 11, 2026. Its market cap has increased by 21.76% in one year.
Market Cap
35.65B
Enterprise Value
25.71B
Revenue
90.79B
Ranking
n/a
PE Ratio
9.41
Stock Price
4,340.00
Market Cap Chart
Since April 28, 2006, GeneBioTech Co. ,Ltd's market cap has decreased from 35.91B to 35.65B, a decrease of -0.74%. That is a compound annual growth rate of -0.04%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| May 11, 2026 | 35.65B | 3.24% |
| Dec 30, 2025 | 34.53B | 21.88% |
| Dec 30, 2024 | 28.33B | -24.54% |
| Dec 28, 2023 | 37.54B | 9.27% |
| Dec 29, 2022 | 34.36B | -23.85% |
| Dec 30, 2021 | 45.12B | -8.87% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Korea Arlico Pharm | 53.26B |
| RP Bio | 53.21B |
| Kyung Nam Pharm | 52.05B |
| Eagle Veterinary Technology Co.,Ltd | 50.06B |
| Korean Drug | 43.76B |
| HLscience | 42.02B |
| Baskhanbio Pharma | 35.06B |
| Seoul Pharma | 31.77B |